CALLEGARI, DONATELLA

CALLEGARI, DONATELLA  

Dipartimento di Scienze degli Alimenti e del Farmaco  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.034 secondi).
Titolo Data di pubblicazione Autore(i) File
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 1-gen-2019 Castelli, R; Bozza, N; Cavazzoni, A; Bonelli, M; Vacondio, F; Ferlenghi, F; Callegari, D; Silva, C; Rivara, S; Lodola, A; Digiacomo, G; Fumarola, C; Alfieri, R; Petronini, Pg; Mor, M.
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 1-gen-2015 Callegari, Donatella; Pala, Daniele; Scalvini, Laura; Tognolini, Massimiliano; Incerti, Matteo; Rivara, Silvia; Mor, Marco; Lodola, Alessio
Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations 1-gen-2020 Lodola, A.; Callegari, D.; Scalvini, L.; Rivara, S.; Mor, M.
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 1-gen-2015 Tognolini, Massimiliano; Giorgio, Carmine; Festuccia, C; Rusnati, M; Chiodelli, P; Incerti, Matteo; Pala, Daniele; Callegari, Donatella; Bertoni, Simona; Castelli, Riccardo; Lodola, Alessio; Barocelli, Elisabetta
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 1-gen-2017 Tognolini, Massimiliano; Claudio, Festuccia; Gianluca, Gravina; Castelli, Riccardo; Incerti, Matteo; Vacondio, Federica; Callegari, Donatella; Simonetta, Russo; Barocelli, Elisabetta; Marco, Rusnati; Paola, Chiodelli; Lodola, Alessio; Giorgio, Carmine
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells 1-gen-2015 Giorgio, Carmine; MENA PARRENO, Pedro Miguel; DEL RIO, Daniele; Brighenti, Furio; Barocelli, Elisabetta; HASSAN MOHAMED, Iftiin; Callegari, Donatella; Lodola, Alessio; Tognolini, Massimiliano
Eph-ephrin antagonism in tumor angiogenesis and growth: UniPR1331 preclinical evidence. 1-gen-2017 Giorgio, Carmine; Festuccia, Claudio; Gravina, Giovanni L.; Castelli, Riccardo; Rusnati, Marco; Chiodelli, Paola; Vacondio, Federica; Pala, Daniele; Callegari, Donatella; Barocelli, Elisabetta; Lodola, Alessio; Tognolini, Massimiliano
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 1-gen-2016 Russo, Simonetta; Callegari, Donatella; Incerti, Matteo; Pala, Daniele; Giorgio, Carmine; Brunetti, Jlenia; Bracci, Luisa; Vicini, Paola; Barocelli, Elisabetta; Capoferri, Luigi; Rivara, Silvia; Tognolini, Massimiliano; Mor, Marco; Lodola, Alessio
L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib 1-gen-2018 Callegari, D.; Ranaghan, K. E.; Woods, C. J.; Minari, R.; Tiseo, M.; Mor, M.; Mulholland, A. J.; Lodola, A.
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 1-gen-2017 Incerti, Matteo; Russo, Simonetta; Callegari, Donatella; Pala, Daniele; Giorgio, Carmine; Zanotti, Ilaria; Barocelli, Elisabetta; Vicini, Paola; Vacondio, Federica; Rivara, Silvia; Castelli, Riccardo; Tognolini, Massimiliano; Lodola, Alessio
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8. 1-gen-2017 Callegari, Donatella; Lodola, Alessio; Pala, Daniele; Rivara, Silvia; Mor, Marco; Rizzi, A; Capelli A., M.
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 1-gen-2015 Tognolini, Massimiliano; Giorgio, Carmine; Incerti, Matteo; Castelli, Riccardo; Festuccia, C.; Rusnati, M.; Vacondio, Federica; Russo, Simonetta; Pala, Daniele; Callegari, Donatella; Mor, Marco; Bertoni, Simona; Ballabeni, Vigilio; Lodola, Alessio; Barocelli, Elisabetta
N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations 1-gen-2020 Scalvini, L.; Ghidini, A.; Lodola, A.; Callegari, D.; Rivara, S.; Piomelli, D.; Mor, M.
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 1-gen-2020 Incerti, M.; Russo, S.; Corrado, M.; Giorgio, C.; Ballabeni, V.; Chiodelli, P.; Rusnati, M.; Scalvini, L.; Callegari, D.; Castelli, R.; Vacondio, F.; Ferlenghi, F.; Tognolini, M.; Lodola, A.
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 1-gen-2018 Giorgio, Carmine; Incerti, Matteo; Corrado, Miriam; Rusnati, Marco; Chiodelli, Paola; Russo, Simonetta; Callegari, Donatella; Ferlenghi, Francesca; Ballabeni, Vigilio; Barocelli, Elisabetta; Lodola, Alessio; Tognolini, Massimiliano
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 1-gen-2015 Castelli, Riccardo; Tognolini, Massimiliano; Vacondio, Federica; Incerti, Matteo; Pala, Daniele; Callegari, Donatella; Bertoni, Simona; Giorgio, Carmine; Hassan Mohamed, I; Zanotti, Ilaria; Bugatti, A; Rusnati, M; Festuccia, C; Rivara, Silvia; Barocelli, Elisabetta; Mor, Marco; Lodola, Alessio